Literature DB >> 31586267

Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease.

Mohammed Eslam1, Jacob George2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31586267     DOI： 10.1007/s12072-019-09990-z

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  23 in total

1.  Echocardiographic epicardial fat thickness and coronary artery disease.

Authors:  Jin-Won Jeong; Myung Ho Jeong; Kyeong Ho Yun; Seok Kyu Oh; Eun Mi Park; Yun Kyung Kim; Sang Jae Rhee; Eun Mi Lee; Je Lee; Nam Jin Yoo; Nam-Ho Kim; Jong Chun Park
Journal:  Circ J       Date:  2007-04       Impact factor: 2.993

2.  Liraglutide causes large and rapid epicardial fat reduction.

Authors:  Gianluca Iacobellis; Mahshid Mohseni; Suzy D Bianco; Pritisheel K Banga
Journal:  Obesity (Silver Spring)       Date:  2017-02       Impact factor: 5.002

Review 3.  The Lives and Times of Brown Adipokines.

Authors:  Francesc Villarroya; Aleix Gavaldà-Navarro; Marion Peyrou; Joan Villarroya; Marta Giralt
Journal:  Trends Endocrinol Metab       Date:  2017-11-04       Impact factor: 12.015

4.  Assessing genetic and environmental influences on epicardial and abdominal adipose tissue quantities: a classical twin study.

Authors:  A L Jermendy; M Kolossvary; Z D Drobni; A D Tarnoki; D L Tarnoki; J Karady; S Voros; H J Lamb; B Merkely; G Jermendy; P Maurovich-Horvat
Journal:  Int J Obes (Lond)       Date:  2017-08-30       Impact factor: 5.095

Review 5.  Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Authors:  Zobair Younossi; Quentin M Anstee; Milena Marietti; Timothy Hardy; Linda Henry; Mohammed Eslam; Jacob George; Elisabetta Bugianesi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-20       Impact factor: 46.802

6.  Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties.

Authors:  J M Marchington; C A Mattacks; C M Pond
Journal:  Comp Biochem Physiol B       Date:  1989

Review 7.  The obesity transition: stages of the global epidemic.

Authors:  Lindsay M Jaacks; Stefanie Vandevijvere; An Pan; Craig J McGowan; Chelsea Wallace; Fumiaki Imamura; Dariush Mozaffarian; Boyd Swinburn; Majid Ezzati
Journal:  Lancet Diabetes Endocrinol       Date:  2019-01-28       Impact factor: 32.069

Review 8.  Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis.

Authors:  Gianluca Perseghin
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

9.  Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis.

Authors:  Yingrui Li; Bin Liu; Yu Li; Xiaodong Jing; Songbai Deng; Yulin Yan; Qiang She
Journal:  Cardiovasc Diabetol       Date:  2019-01-10       Impact factor: 9.951

10.  Ectopic cardiovascular fat in middle-aged men: effects of race/ethnicity, overall and central adiposity. The ERA JUMP study.

Authors:  S R El Khoudary; C Shin; K Masaki; K Miura; M Budoff; D Edmundowicz; S Kadowaki; E Barinas-Mitchell; A El-Saed; A Fujiyoshi; R W Evans; T Hisamatsu; T Ohkubo; B J Willcox; L H Kuller; H Ueshima; A Sekikawa
Journal:  Int J Obes (Lond)       Date:  2014-08-11       Impact factor: 5.095
View more
  4 in total

1.  The correlation between hepatic fat fraction evaluated by dual-energy computed tomography and high-risk coronary plaques in patients with non-alcoholic fatty liver disease.

Authors:  Rui Zhan; Rongxing Qi; Sheng Huang; Yang Lu; Xiaoyu Wang; Jiashen Jiang; Xiwu Ruan; Anyi Song
Journal:  Jpn J Radiol       Date:  2021-04-05       Impact factor: 2.374

Review 2.  Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight.

Authors:  Mohammed Eslam; Hashem B El-Serag; Sven Francque; Shiv K Sarin; Lai Wei; Elisabetta Bugianesi; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-06-16       Impact factor: 73.082

Review 3.  Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases.

Authors:  Jorge Gutiérrez-Cuevas; Arturo Santos; Juan Armendariz-Borunda
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

4.  Network Pharmacology-Based Analysis of Pogostemon cablin (Blanco) Benth Beneficial Effects to Alleviate Nonalcoholic Fatty Liver Disease in Mice.

Authors:  Yizhe Cui; Qiuju Wang; Renxu Chang; Ahmad Aboragah; Juan J Loor; Chuang Xu
Journal:  Front Pharmacol       Date:  2021-11-24       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.